Literature DB >> 31870920

Hepatic injury and inflammation alter ethanol metabolism and drinking behavior.

Tianyi Ren1, Bryan Mackowiak2, Yuhong Lin2, Yanhang Gao3, Junqi Niu4, Bin Gao5.   

Abstract

While liver injury is commonly associated with excessive alcohol consumption, how liver injury affects alcohol metabolism and drinking preference remains unclear. To answer these questions, we measured the expression and activity of alcohol dehydrogenase 1 (ADH1) and acetaldehyde dehydrogenase 2 (ALDH2) enzymes, ethanol and acetaldehyde levels in vivo, and binge-like and preferential drinking behaviors with drinking in the dark and two-bottle choice in animal models with liver injury. Acute and chronic carbon tetrachloride (CCl4), and acute LPS-induced liver injury repressed hepatic ALDH2 activity and expression and consequently, blood and liver acetaldehyde concentrations were increased in these models. In addition, chronic CCl4 and acute LPS treatment inhibited hepatic ADH1 expression and activity, leading to increases in blood and liver ethanol concentrations. Consistent with the increase in acetaldehyde levels, alcohol drinking behaviors were reduced in mice with acute or chronic liver injury. Furthermore, oxidative stress induced by hydrogen peroxide attenuated ADH1 and ALDH2 activity post-transcriptionally, while proinflammatory cytokines led to transcriptional repression of ADH1 and ALDH2 in cultured hepatocytes, which correlated with the repression of transcription factor HNF4α. Collectively, our data suggest that alcohol metabolism is suppressed by inflammation and oxidative stress, which is correlated with decreased drinking behavior. Published by Elsevier Ltd.

Entities:  

Keywords:  ADH1; ALDH2; Alcohol; Cytokine; HNF; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 31870920      PMCID: PMC6948100          DOI: 10.1016/j.fct.2019.111070

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  52 in total

1.  Alcohol Use in Patients with Chronic Liver Disease.

Authors:  Daniel Fuster; Jeffrey H Samet
Journal:  N Engl J Med       Date:  2018-12-27       Impact factor: 91.245

2.  Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: implications for risk assessment.

Authors:  Gary Ginsberg; Susan Smolenski; Dale Hattis; Babasaheb Sonawane
Journal:  Regul Toxicol Pharmacol       Date:  2002-12       Impact factor: 3.271

3.  Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage.

Authors:  María Pascual; Pablo Baliño; Silvia Alfonso-Loeches; Carlos M G Aragón; Consuelo Guerri
Journal:  Brain Behav Immun       Date:  2011-02-23       Impact factor: 7.217

4.  The association of ADH and ALDH gene variants with alcohol drinking habits and cardiovascular disease risk factors.

Authors:  Lise Lotte Nystrup Husemoen; Mogens Fenger; Nele Friedrich; Janne Schurmann Tolstrup; Stine Beenfeldt Fredriksen; Allan Linneberg
Journal:  Alcohol Clin Exp Res       Date:  2008-09-06       Impact factor: 3.455

5.  Ethanol metabolism in ALDH2 knockout mice--blood acetate levels.

Authors:  Ameno Kiyoshi; Wang Weihuan; Jamal Mostofa; Kumihashi Mitsuru; Isse Toyoshi; Kawamoto Toshihiro; Kitagawa Kyoko; Nakayama Keiichi; Ijiri Iwao; Kinoshita Hiroshi
Journal:  Leg Med (Tokyo)       Date:  2009-04-07       Impact factor: 1.376

6.  Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation.

Authors:  Kwan-Hoon Moon; Young-Mi Lee; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2009-11-14       Impact factor: 7.376

7.  Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.

Authors:  Hongguang Han; Huishan Wang; Zongtao Yin; Hui Jiang; Minhua Fang; Jingsong Han
Journal:  Gene       Date:  2013-05-16       Impact factor: 3.688

8.  Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking.

Authors:  Adrien Guillot; Tianyi Ren; Tony Jourdan; Robert J Pawlosky; Elaine Han; Seung-Jin Kim; Li Zhang; George F Koob; Bin Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-02       Impact factor: 11.205

9.  Interleukin-22 Ameliorates Neutrophil-Driven Nonalcoholic Steatohepatitis Through Multiple Targets.

Authors:  Seonghwan Hwang; Yong He; Xiaogang Xiang; Wonhyo Seo; Seung-Jin Kim; Jing Ma; Tianyi Ren; Seol Hee Park; Zhou Zhou; Dechun Feng; George Kunos; Bin Gao
Journal:  Hepatology       Date:  2020-03-16       Impact factor: 17.298

10.  Low Km aldehyde dehydrogenase (ALDH2) polymorphism, alcohol-drinking behavior, and chromosome alterations in peripheral lymphocytes.

Authors:  K Morimoto; T Takeshita
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

View more
  4 in total

Review 1.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

Review 2.  Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.

Authors:  Qiaoling Wang; Binxia Chang; Xiaoyan Li; Zhengsheng Zou
Journal:  J Clin Transl Hepatol       Date:  2021-01-04

Review 3.  Impact of Alcohol Consumption on Male Fertility Potential: A Narrative Review.

Authors:  Renata Finelli; Filomena Mottola; Ashok Agarwal
Journal:  Int J Environ Res Public Health       Date:  2021-12-29       Impact factor: 3.390

4.  D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease.

Authors:  Mengyao Hu; Yu Chen; Fan Deng; Bo Chang; Jialiang Luo; Lijun Dong; Xiao Lu; Yi Zhang; Zhengliang Chen; Jia Zhou
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.